Skip to main content

Please wait ...

Rick Doblin, PhD


Rick Doblin, Ph.D., Executive Director, Multidisciplinary Association for Psychedelic Studies (MAPS); chair of the board of directors MAPS Public Benefit Corporation.

 

Speaker Disclosures:
Financial: Richard Doblin has an employment relationship with Multidisciplinary Association for Psychedelic Studies, Inc. He receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Richard Doblin has no relevant non-financial relationships.

Emerging Psychedelic Treatments: Opportunities and Challenges


Faculty:
Michael Mithoefer, MD |  Rick Doblin, PhD
Duration:
3 Hours 55 Minutes
Format:
Audio and Video
Copyright:
Mar 12, 2022
Product Code:
NOS096211
Media Type:
Digital Seminar
Price:
$199.99 - Standard

Showing 1 to 1 of 1 entries